Agape ATP (NASDAQ:ATPC – Get Free Report) and Lifevantage (NASDAQ:LFVN – Get Free Report) are both small-cap consumer staples companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, institutional ownership, valuation, dividends and profitability.
Volatility & Risk
Agape ATP has a beta of 0.55, indicating that its share price is 45% less volatile than the S&P 500. Comparatively, Lifevantage has a beta of 0.71, indicating that its share price is 29% less volatile than the S&P 500.
Institutional and Insider Ownership
0.0% of Agape ATP shares are owned by institutional investors. Comparatively, 35.3% of Lifevantage shares are owned by institutional investors. 2.0% of Agape ATP shares are owned by insiders. Comparatively, 13.6% of Lifevantage shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Analyst Ratings
This is a summary of current ratings for Agape ATP and Lifevantage, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Agape ATP | 1 | 0 | 0 | 0 | 1.00 |
| Lifevantage | 1 | 2 | 0 | 0 | 1.67 |
Lifevantage has a consensus price target of $5.50, indicating a potential upside of 9.67%. Given Lifevantage’s stronger consensus rating and higher probable upside, analysts clearly believe Lifevantage is more favorable than Agape ATP.
Profitability
This table compares Agape ATP and Lifevantage’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Agape ATP | -85.94% | -5.47% | -4.94% |
| Lifevantage | 1.58% | 16.35% | 8.90% |
Earnings & Valuation
This table compares Agape ATP and Lifevantage”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Agape ATP | $1.52 million | 0.92 | -$2.28 million | ($0.74) | -1.90 |
| Lifevantage | $172.14 million | 0.37 | $5.07 million | $0.21 | 23.88 |
Lifevantage has higher revenue and earnings than Agape ATP. Agape ATP is trading at a lower price-to-earnings ratio than Lifevantage, indicating that it is currently the more affordable of the two stocks.
Summary
Lifevantage beats Agape ATP on 12 of the 13 factors compared between the two stocks.
About Agape ATP
Agape ATP Corporation is a health and wellness company focused on providing personalized healthcare-related services, wellness programs and nutritional products. Its offerings are designed to support preventive health management, healthy aging and overall well-being. The company serves customers primarily through its operations in Malaysia and has marketed products and services connected with health assessments, nutrition and lifestyle management. Its business model combines wellness consultations with health-oriented consumer products and services.
About Lifevantage
LifeVantage Corporation is a health and wellness company that develops, markets and distributes dietary supplements and personal-care products. Its product portfolio is designed to support areas such as cellular health, antioxidant defenses, energy, nutrition and skin care. The company’s principal brands have included Protandim, a line of dietary supplements; TrueScience, a skin-care and wellness brand; and Petandim, products formulated for pets. LifeVantage primarily uses a direct-selling business model, distributing its products through independent sales representatives and online channels.
Receive News & Ratings for Agape ATP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agape ATP and related companies with MarketBeat.com's FREE daily email newsletter.
